REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 80 filers reported holding REPROS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $13,672,000 | -2.6% | 790,264 | -0.1% | 0.01% | 0.0% |
| Q1 2014 | $14,033,000 | +1.6% | 791,064 | +4.8% | 0.01% | 0.0% |
| Q4 2013 | $13,807,000 | +1.2% | 754,477 | +48.2% | 0.01% | -7.1% |
| Q3 2013 | $13,643,000 | +16.8% | 509,073 | -19.6% | 0.01% | +16.7% |
| Q2 2013 | $11,676,000 | – | 632,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,413,000 | 2.08% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,445,000 | 0.72% |
| RTW INVESTMENTS, LP | 232,830 | $1,730,000 | 0.54% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 185,500 | $1,378,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 509,060 | $3,782,000 | 0.34% |
| Opus Point Partners Management, LLC | 98,000 | $494,000 | 0.27% |
| J. Goldman & Co LP | 350,000 | $2,601,000 | 0.22% |
| CQS Cayman LP | 240,000 | $1,783,000 | 0.15% |
| Baker Brothers Advisors | 1,955,944 | $14,533,000 | 0.13% |
| Perceptive Advisors | 440,000 | $3,270,000 | 0.13% |